WeVote
Log In

Bill

Bill

H 2414

An Act relative to patient assessment and notification prior to prescribing certain medications

194th Legislature (2025-2026) Introduced by Carole Fiola and 2 co-sponsors

Massachusetts bill requiring healthcare providers to assess patients and provide written notice before prescribing certain high-risk medications to improve informed consent and patient safety.

Reporting date extended to Friday, July 31, 2026
0
WeVote Research Nonpartisan
Bill Summary · H 2414

Legislative bill overview

H 2414 requires healthcare providers to conduct patient assessments and provide written notification before prescribing certain medications, likely focusing on drugs with significant side effects or abuse potential. The bill establishes informed consent procedures and documentation requirements prior to medication initiation.

Why is this important

Medication-related adverse events and inappropriate prescribing contribute substantially to preventable patient harm and healthcare costs. This bill seeks to strengthen patient safety and autonomy by ensuring informed decision-making before starting potentially problematic medications, particularly relevant for opioids, benzodiazepines, or other high-risk drug classes.

Potential points of contention

  • Definition scope: Unclear which specific medications trigger these requirements, potentially creating compliance confusion or regulatory overreach
  • Administrative burden: Requiring written assessments and notifications may increase healthcare provider workload and patient visit times, raising costs
  • Implementation feasibility: Determining what constitutes adequate "patient assessment" and notification standards could face challenges without clear regulatory guidance

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.